Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
Herbert Loong on Twitter: "Amazing work @ZerAlona and colleagues! Thanks for leading the way for the entire world in confirming the importance of timely administration of #COVID19 vaccination in patients." / Twitter
Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses
Overall survival results from the phase III MONALEESA-2 trial of postmenopausal patients with HR+/HER2- advanced breast cancer
![Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology](https://www.frontiersin.org/files/Articles/499663/fonc-10-00191-HTML/image_m/fonc-10-00191-g001.jpg)